Tirz-Luxe 10mg (Tirzepatide)

Description

Tirzepatide 10mg (Tirz-Luxe), with identity and reports in one place

Purity Collective supplies Tirzepatide 10mg under the Tirz-Luxe catalog name in a lyophilized vial for qualified laboratory research. This page places the compound identity, listed quantity, SKU and available analytical records together so a purchasing team can evaluate the listing without relying on human outcomes, clinical positioning or blanket testing promises.

A useful procurement record keeps catalog facts separate from sample results. The 10mg quantity is the listed product amount. The numerical measurements below belong to the submitted samples identified in their reports and should not be generalized to every vial, lot or future batch.

Product details

Available analytical documents

Open the Tirzepatide 10mg UPLC/MS report and the Tirzepatide endotoxin report to inspect the complete records. Purity Collective’s guide to reading a peptide COA explains how to compare identity, lot, method, dates, specification and result fields. For identity/source context and 10mg-versus-30mg evidence boundaries, read the Tirzepatide research records and COA review guide.

The two-page UPLC/MS report identifies Tirzepatide and lot PCCL-2576448-P. For that submitted sample, it records 10.1mg against a 10mg specification and 99.35% purity against a greater-than-98% specification. The report lists May 4, 2026 as the analysis date and May 9, 2026 as the received date, placing the stated analysis five days before receipt.

The separate endotoxin document uses the related lot identifier PCCL-2576448-E and records a result below 0.05 EU/mL. It prints no endotoxin acceptance specification and repeats the same analysis-before-receipt chronology. The storefront certificate card currently lists April 5, 2026 as its test date, while both attached reports print May 4, 2026 as the analysis date. These differences are preserved here for review rather than silently reconciled.

Keep the catalog identity and evidence boundary clear

Tirz-Luxe is the catalog name; Tirzepatide is the compound identity printed in both reports. The page does not call the endotoxin result a pass and does not use either report to establish sterility, safety, suitability or performance. A qualified reviewer should resolve the printed chronology and storefront date discrepancy under the laboratory’s own supplier-qualification procedures.

Before you order

• Confirm that Tirzepatide, the 10mg listed quantity and SKU PC-TIRZ-LUXE-10MG match the procurement request.
• Review both reports in full, including the -P and -E lot identifiers, methods, dates, specifications and results.
• Keep the 10.1mg and 99.35% measurements tied to the submitted UPLC/MS sample.
• Record that both reports list analysis five days before receipt and that the storefront card uses a different test date.
• Apply your laboratory’s own supplier-qualification, acceptance, storage and handling procedures.

Tirzepatide 10mg FAQs

What is Tirz-Luxe 10mg?

Tirz-Luxe 10mg is Purity Collective’s catalog name for a Tirzepatide reference material supplied in a lyophilized vial under SKU PC-TIRZ-LUXE-10MG for qualified laboratory research.

Which analytical documents are available?

The page links directly to a two-page UPLC/MS report and a separate endotoxin report. Each should be reviewed as a complete record, including its compound, lot, method, dates, specifications and results.

What does the UPLC/MS report show?

For submitted lot PCCL-2576448-P, the report records 10.1mg against a 10mg specification and a purity result of 99.35% against a greater-than-98% specification. These are sample-specific measurements, not universal guarantees.

What document limitations should a reviewer record?

Both reports list analysis on May 4, 2026 and receipt on May 9, 2026. The endotoxin report prints no acceptance specification, and the storefront certificate card lists April 5, 2026 as its test date. This page does not interpret those discrepancies as resolved.

Is Tirzepatide 10mg intended for human use?

No. This product is supplied only for qualified laboratory research and is not for human or veterinary administration. Purity Collective does not provide clinical, therapeutic, dosing or administration guidance.

Research-use notice

For qualified laboratory research only. Not for human or veterinary administration. This listing is not presented as a medicine or treatment.